| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |